Response to growth hormone therapy in adolescents with familial panhypopituitarism
Authors:
- 1 April 2010
- journal article
- case report
- Published by Springer Nature in Indian Pediatrics
- Vol. 47 (4) , 356-358
Abstract
Familial combined pituitary hormone deficiency is a rare endocrine disorder. We describe growth patterns of four children (3 females and 1 male) from two families with combined pituitary hormone deficiency. These children received growth hormone at ages ranging from 14.5 years to 19 years. While all the female siblings reached their target height, the male sibling was much shorter than mid parental height. The reasons for sexual dimorphism in growth patterns in these children are unclear.Keywords
This publication has 5 references indexed in Scilit:
- Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD)Clinical Endocrinology, 2005
- Growth Hormone Therapy in Children after Cranial/Craniospinal Radiation Therapy: Sexually Dimorphic OutcomesThe Journal of Clinical Endocrinology & Metabolism, 2004
- Central hypocortisolism as part of combined pituitary hormone deficiency due to mutations of PROP-1 geneEuropean Journal of Endocrinology, 2000
- Growth hormone and androgen effects in the third decadeEuropean Journal of Endocrinology, 1986
- Pubertal Growth and Final Height in Hypopituitary Boys: A Minor Role of Bone Age at Onset of Puberty*The Journal of Clinical Endocrinology & Metabolism, 1986